P&G Hygiene

INR
9,269.80
259.45 (2.88%)
BSENSE

Jun 19, 03:30 PM

BSE+NSE Vol: 49.99 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

49.99 k (-66.51%) Volume

Shareholding (Mar 2026)

FII

0.97%

Held by 101 FIIs

DII

15.97%

Held by 19 DIIs

Promoter

70.64%

Why is Procter & Gamble Hygiene & Health Care Ltd. falling/rising?

20-Jun-2026

As of 19-Jun, Procter & Gamble Hygiene & Health Care Ltd. has seen its stock price rise to Rs 9,269.80, up 2.88% due to increased investor interest and recent gains, despite a significant year-to-date decline of 28.36%. The stock has outperformed its sector today and shows a positive short-term trend.

As of 19-Jun, Procter & Gamble Hygiene & Health Care Ltd. is experiencing a rise in its stock price, currently at Rs 9,269.80, reflecting a change of 259.45 (2.88%) upwards. This increase can be attributed to several factors. Notably, the stock has outperformed its sector by 3.26% today and has been gaining for the last two days, with a total return of 3.01% during this period. Additionally, the stock reached an intraday high of Rs 9,389, marking a 4.2% increase.<BR><BR>Investor participation has also risen significantly, with delivery volume on June 18 increasing by 95.22% compared to the 5-day average, indicating heightened interest among investors. Furthermore, the stock is currently trading higher than its 5-day moving averages, which may suggest a short-term positive trend.<BR><BR>Despite these positive indicators, it is important to note that the stock has faced challenges in the longer term, including a significant decline of 28.36% year-to-date and a 31.02% drop over the past year. However, the recent performance and rising investor participation may be contributing to the current upward movement in the stock price.

View full answer

How big is P&G Hygiene?

11-Jun-2026

As of 10th June, Procter & Gamble Hygiene & Health Care Ltd. has a market capitalization of 29,536.00 Cr, with recent net sales of 4,281.59 Cr and a net profit of 856.51 Cr over the last four quarters.

As of 10th June, <BR><BR>Market Cap: Procter & Gamble Hygiene & Health Care Ltd. has a market capitalization of 29,536.00 Cr, categorizing it as a Mid Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 4,281.59 Cr, while the sum of Net Profit for the same period is 856.51 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period for the balance sheet is March 2025, with Shareholder's Funds amounting to 736.99 Cr and Total Assets totaling 1,672.31 Cr.

View full answer

Who are in the management team of P&G Hygiene?

11-Jun-2026

The management team of P&G Hygiene includes A K Gupta, Sonali Dhawan, Karthik Natarajan, Pramod Agarwal, Gagan Sawhney, Meena Ganesh, Ghanashyam Hedge, Chittranjan Dua, Krishnamurthy Narayanan Iyer, L. V. Vaidyanathan, and Gurcharan Das, featuring a mix of directors and independent directors. If you need details about specific members or their roles, feel free to ask!

The management team of P&G Hygiene includes the following individuals:<BR><BR>1. A K Gupta - Independent Director<BR>2. Sonali Dhawan - Director<BR>3. Karthik Natarajan - Director<BR>4. Pramod Agarwal - Director<BR>5. Gagan Sawhney - Director<BR>6. Meena Ganesh - Independent Director<BR>7. Ghanashyam Hedge - Executive Director & Secretary<BR>8. Chittranjan Dua - Chairman & Independent Director<BR>9. Krishnamurthy Narayanan Iyer - Independent Director<BR>10. L. V. Vaidyanathan - Managing Director<BR>11. Gurcharan Das - Independent Director<BR><BR>This team brings a diverse range of expertise to the company. If you need more specific information about any of the members or their roles, feel free to ask!

View full answer

Who are the peers of the P&G Hygiene?

11-Jun-2026

P&G Hygiene's peers include Tata Consumer, Godrej Consumer, Dabur India, Colgate-Palmoliv, Godfrey Phillips, Gillette India, Cupid, Hatsun Agro, Emami, and Bikaji Foods. P&G Hygiene has a low 1-year return of -32.82%, while Cupid leads with 698.05%.

Peers: The peers of P&G Hygiene are Tata Consumer, Godrej Consumer, Dabur India, Colgate-Palmoliv, Godfrey Phillips, Gillette India, Cupid, Hatsun Agro, Emami, and Bikaji Foods.<BR><BR>Quality Snapshot: Excellent management risk is observed at Colgate-Palmoliv, Godfrey Phillips, Gillette India, Emami, and P&G Hygiene, while Good management risk is found at Godrej Consumer, Dabur India, and Hatsun Agro. Average management risk is present at Tata Consumer and Cupid. Growth ratings show Excellent growth at Godfrey Phillips, Good growth at Tata Consumer and Cupid, and Below Average growth at Godrej Consumer, Dabur India, Colgate-Palmoliv, P&G Hygiene, Gillette India, Hatsun Agro, Emami, and Bikaji Foods. Capital Structure is rated Excellent for Tata Consumer, Godrej Consumer, Dabur India, Colgate-Palmoliv, Godfrey Phillips, P&G Hygiene, Gillette India, Cupid, and Emami, while Average capital structure is noted for Hatsun Agro.<BR><BR>Return Snapshot: Cupid has the highest 1-year return at 698.05%, while P&G Hygiene has the lowest at -32.82%. This indicates that P&G Hygiene's 1-year return is significantly lower than that of Cupid. Additionally, the six-month return is negative for P&G Hygiene, Godrej Consumer, Dabur India, Colgate-Palmoliv, Godfrey Phillips, Emami, and Hatsun Agro.

View full answer

What does P&G Hygiene do?

10-Jun-2026

Procter & Gamble Hygiene and Health Care Limited (P&GHHCL) manufactures and sells branded fast-moving consumer goods in the femcare and healthcare sectors. As of March 2026, it reported net sales of 938 Cr and a net profit of 153 Cr, with a market cap of INR 29,536 Cr.

Overview:<BR>Procter & Gamble Hygiene and Health Care Limited (P&GHHCL) is engaged in manufacturing and selling branded packaged fast moving consumer goods in the femcare and healthcare sectors, operating within the FMCG industry as a mid-cap company.<BR><BR>History:<BR>P&GHHCL was incorporated in an unspecified year and has maintained its status as a key player in the FMCG sector. The latest quarterly results reported are for March 2026, showcasing the company's performance in net sales and profit.<BR><BR>Financial Snapshot:<BR>- Net Sales: 938 Cr (Quarterly Results - Mar 2026)<BR>- Net Profit: 153 Cr (Quarterly Results - Mar 2026)<BR>- Market Cap: INR 29,536 Cr (Mid Cap)<BR><BR>Key Metrics:<BR>- P/E: 34.00<BR>- Industry P/E: 45<BR>- Dividend Yield: 2.87%<BR>- Debt Equity: -0.75<BR>- Return on Equity: 113.68%<BR>- Price to Book: 39.04<BR><BR>Contact Details:<BR>Address: P & G Plaza Chakala, Cardinal Gracias Rd Andheri(E) Mumbai Maharashtra : 400099<BR>Tel: 91-22-28266000<BR>Email: investorpghh.i@pg.com<BR>Website: http://www.in.pg.com

View full answer

Should I buy, sell or hold Procter & Gamble Hygiene & Health Care Ltd.?

30-May-2026

Are Procter & Gamble Hygiene & Health Care Ltd. latest results good or bad?

29-May-2026

Procter & Gamble Hygiene & Health Care Ltd.'s latest results are disappointing, with a 1.90% decline in net profit and a 5.20% drop in net sales year-on-year, raising concerns about the company's growth in a competitive FMCG market. Despite improved operating margins, the overall performance reflects significant challenges, leading to negative market reactions.

Procter & Gamble Hygiene & Health Care Ltd.'s latest results indicate a challenging period for the company. In the fourth quarter of FY26, the company reported a net profit of ₹153.13 crores, which represents a 1.90% decline year-on-year. Additionally, net sales fell by 5.20% year-on-year to ₹937.67 crores. This decline in sales is particularly concerning as it highlights the company's struggle to drive growth in a competitive FMCG market.<BR><BR>While the operating margin improved to 23.28%, up 208 basis points from the previous year, this was not enough to offset the overall decline in revenue. The full-year performance also reflects significant challenges, with a 19.80% decrease in consolidated net sales compared to the previous fiscal year.<BR><BR>The market reaction has been negative, with the stock trading down significantly and underperforming the FMCG sector. Investors are expressing concerns about the company's stagnant growth trajectory and high valuation, especially given the backdrop of a generally resilient FMCG sector where many competitors are managing to achieve growth.<BR><BR>Overall, the results can be characterized as disappointing, raising questions about the company's competitive positioning and ability to capitalize on market opportunities.

View full answer

Has Procter & Gamble Hygiene & Health Care Ltd. declared dividend?

01-Feb-2026

Yes, Procter & Gamble Hygiene & Health Care Ltd. has declared a dividend of 1700% (₹65 per share), with an ex-date of February 5, 2026. Despite the significant dividend, total returns have been negative over shorter periods, improving in the long term.

Procter & Gamble Hygiene & Health Care Ltd. has declared a dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 1700%<BR>- Amount per share: 65<BR>- Ex-date: 05 Feb 26<BR><BR>Dividend Yield: 1.49%.<BR><BR>Total Returns by Period:<BR>In the 3-month period, the price return was -11.01%, the dividend return was 0.19%, resulting in a total return of -10.82%.<BR><BR>In the 6-month period, the price return was -14.1%, the dividend return was 0.68%, leading to a total return of -13.42%.<BR><BR>For the 1-year period, the price return was -17.41%, the dividend return was 1.38%, culminating in a total return of -16.03%.<BR><BR>Over the 2-year period, the price return was -30.52%, the dividend return was 1.80%, resulting in a total return of -28.72%.<BR><BR>In the 3-year period, the price return was -13.29%, the dividend return was 3.36%, leading to a total return of -9.93%.<BR><BR>During the 4-year period, the price return was -17.88%, the dividend return was 3.91%, culminating in a total return of -13.97%.<BR><BR>In the 5-year period, the price return was 5.2%, the dividend return was 7.14%, resulting in a total return of 12.34%.<BR><BR>Overall, while Procter & Gamble Hygiene & Health Care Ltd. has declared a significant dividend, the total returns over various periods indicate a trend of negative performance, particularly in the shorter time frames, with a more favorable outcome in the longer term.

View full answer

Has Procter & Gamble Hygiene & Health Care Ltd. declared dividend?

01-Feb-2026

Yes, Procter & Gamble Hygiene & Health Care Ltd. has declared a dividend of 1700% (₹65 per share) with an ex-date of August 28, 2025. Despite this, the company has experienced negative total returns over the past 1 to 4 years, though it showed a positive return of 12.34% over the last 5 years.

Procter & Gamble Hygiene & Health Care Ltd. has declared a dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 1700%<BR>- Amount per share: 65<BR>- Ex-date: Aug-28-2025<BR><BR>Dividend Yield: 1.49%.<BR><BR>Total Returns by Period:<BR>Over the past 3 months, the price return was -11.01%, the dividend return was 0.19%, resulting in a total return of -10.82%.<BR><BR>In the last 6 months, the price return decreased by -14.1%, with a dividend return of 0.68%, leading to a total return of -13.42%.<BR><BR>For the 1-year period, the price return was -17.41%, the dividend return was 1.38%, culminating in a total return of -16.03%.<BR><BR>Over 2 years, the price return fell by -30.52%, the dividend return was 1.80%, resulting in a total return of -28.72%.<BR><BR>In the 3-year period, the price return was -13.29%, the dividend return was 3.36%, leading to a total return of -9.93%.<BR><BR>For the 4-year period, the price return decreased by -17.88%, with a dividend return of 3.91%, resulting in a total return of -13.97%.<BR><BR>In the 5-year span, the price return increased by 5.2%, the dividend return was 7.14%, leading to a total return of 12.34%.<BR><BR>Overall, while Procter & Gamble Hygiene & Health Care Ltd. has declared a significant dividend, the total returns over various periods indicate a challenging performance, particularly in the shorter terms, with negative returns dominating. However, the 5-year period shows a positive total return, suggesting potential recovery or growth in the long term.

View full answer

How has been the historical performance of P&G Hygiene?

06-Nov-2025

P&G Hygiene has shown consistent growth in net sales, reaching 4,191.57 Cr in June 2024, but experienced a slight decline in profit after tax and cash flow from operating activities. Total assets and liabilities decreased, indicating potential restructuring despite strong sales performance.

Answer:<BR>The historical performance of P&G Hygiene shows a consistent upward trend in net sales and operating profit over the years, with net sales reaching 4,191.57 Cr in June 2024, up from 3,905.21 Cr in June 2023 and 3,792.45 Cr in June 2022. Operating profit also increased to 1,022.69 Cr in June 2024 from 909.21 Cr in June 2023. However, profit after tax saw a slight decline to 675.02 Cr in June 2024 from 678.14 Cr in June 2023. The company's total assets decreased to 1,783.69 Cr in June 2024 from 2,071.78 Cr in June 2023, while total liabilities also fell to 1,783.69 Cr in June 2024 from 2,071.78 Cr in June 2023. Cash flow from operating activities decreased to 470.00 Cr in June 2024 from 825.00 Cr in June 2023, indicating a tightening in cash generation.<BR><BR>Breakdown:<BR>P&G Hygiene has demonstrated a robust growth trajectory in net sales, which climbed from 3,001.99 Cr in June 2020 to 4,191.57 Cr in June 2024, reflecting a strong demand for its products. Operating profit, excluding other income, also showed a positive trend, increasing from 603.71 Cr in June 2020 to 970.44 Cr in June 2024, although the profit after tax slightly declined in the latest fiscal year. The company's total assets and liabilities both decreased in June 2024 compared to the previous year, suggesting a potential restructuring or reduction in operational scale. Furthermore, cash flow from operating activities has seen a decline, which may indicate challenges in maintaining liquidity despite the growth in sales and profits. Overall, while P&G Hygiene has achieved significant sales growth, the fluctuations in profit margins and cash flow warrant close monitoring.

View full answer

Is P&G Hygiene technically bullish or bearish?

04-Nov-2025

As of November 3, 2025, P&G Hygiene's trend is mildly bearish, influenced by daily moving averages and monthly MACD signals, despite some mildly bullish indicators on the weekly MACD.

As of 3 November 2025, the technical trend for P&G Hygiene has changed from bearish to mildly bearish. The current stance is mildly bearish, primarily driven by the daily moving averages indicating bearish momentum and the monthly MACD showing a bearish signal. The weekly MACD is mildly bullish, but this is offset by the monthly Bollinger Bands and KST both indicating bearish conditions. The RSI shows no signal in both weekly and monthly time frames, suggesting a lack of strong momentum in either direction. Overall, the mixed signals across different indicators reflect a weak bearish sentiment.

View full answer

Who are the top shareholders of the P&G Hygiene?

17-Jul-2025

The top shareholder of P&G Hygiene is Procter And Gamble Overseas India B.V. with 68.73%. Other significant shareholders include mutual funds at 8.26%, individual investors at 9.76%, and Foreign Institutional Investors at 1.33%.

The top shareholders of P&G Hygiene include Procter And Gamble Overseas India B.V., which holds the largest stake at 68.73%. Additionally, mutual funds collectively hold 8.26% through 15 schemes, with the SBI Focused Equity Fund being the highest public shareholder at 5.73%. Foreign Institutional Investors (FIIs) hold 1.33% through 108 entities, while individual investors account for 9.76% of the shareholding. There are no pledged promoter holdings reported.

View full answer

When is the next results date for P&G Hygiene?

06-Jun-2025

No Upcoming Board Meetings

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Poor long term growth as Net Sales has grown by an annual rate of 4.63% and Operating profit at 5.40% over the last 5 years

 
2

Flat results in Mar 26

3

With ROE of 113.7, it has a Expensive valuation with a 39.9 Price to Book Value

4

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

FMCG

stock-summary
Market cap

INR 29,961 Cr (Mid Cap)

stock-summary
P/E

35.00

stock-summary
Industry P/E

46

stock-summary
Dividend Yield

2.89%

stock-summary
Debt Equity

-0.75

stock-summary
Return on Equity

113.68%

stock-summary
Price to Book

38.80

Revenue and Profits:
Net Sales:
938 Cr
(Quarterly Results - Mar 2026)
Net Profit:
153 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (2.89%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-6.4%
0%
-6.4%
6 Months
-27.45%
1.32%
-26.13%
1 Year
-31.02%
1.76%
-29.26%
2 Years
-43.64%
2.63%
-41.01%
3 Years
-33.4%
4.06%
-29.34%
4 Years
-30.47%
5.36%
-25.11%
5 Years
-30.05%
7.21%
-22.84%

Latest dividend: 170.37889830508473 per share ex-dividend date: Feb-05-2026

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Announcements stock-summary

Company Reply To Clarification Sought By The Exchange

19-Jun-2026 | Source : BSE

Please find enclosed letter as sought from the Company regarding Volume Movement across Exchanges

Clarification sought from Procter & Gamble Hygiene and Health Care Ltd

19-Jun-2026 | Source : BSE

The Exchange has sought clarification from Procter & Gamble Hygiene and Health Care Ltd on June 19 2026 with reference to Movement in Volume.

The reply is awaited.

Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Regulations 2015

19-Jun-2026 | Source : BSE

Please find enclosed disclosure under Regulation 7(2) of the SEBI (PIT) Regulations 2015

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Procter & Gamble Hygiene & Health Care Ltd. has declared 1700% dividend, ex-date: 05 Feb 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
4.63%
EBIT Growth (5y)
5.40%
EBIT to Interest (avg)
72.55
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.75
Sales to Capital Employed (avg)
4.78
Tax Ratio
26.58%
Dividend Payout Ratio
89.23%
Pledged Shares
0
Institutional Holding
16.93%
ROCE (avg)
-102.93%
ROE (avg)
82.27%

Valuation key factors

Factor
Value
P/E Ratio
35
Industry P/E
46
Price to Book Value
39.94
EV to EBIT
26.04
EV to EBITDA
25.21
EV to Capital Employed
158.39
EV to Sales
6.88
PEG Ratio
1.82
Dividend Yield
2.80%
ROCE (Latest)
608.16%
ROE (Latest)
113.68%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 18 Schemes (8.65%)

FIIs

Held by 101 FIIs (0.97%)

Promoter with highest holding

Procter And Gamble Overseas India B.v. (68.73%)

Highest Public shareholder

Sbi Focused Fund (5.06%)

Individual Investors Holdings

9.8%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -5.20% vs -0.90% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -1.90% vs 1.12% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "937.67",
          "val2": "989.13",
          "chgp": "-5.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "218.31",
          "val2": "209.65",
          "chgp": "4.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.11",
          "val2": "5.77",
          "chgp": "-46.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "153.13",
          "val2": "156.10",
          "chgp": "-1.90%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "23.28%",
          "val2": "21.20%",
          "chgp": "2.08%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,084.01",
          "val2": "2,060.16",
          "chgp": "1.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "550.93",
          "val2": "408.82",
          "chgp": "34.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.67",
          "val2": "1.88",
          "chgp": "95.21%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "401.92",
          "val2": "292.96",
          "chgp": "37.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "26.44%",
          "val2": "19.84%",
          "chgp": "6.60%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 1.13% vs 1.29% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 25.26% vs -5.46% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,343.92",
          "val2": "3,306.41",
          "chgp": "1.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "952.73",
          "val2": "779.75",
          "chgp": "22.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "6.34",
          "val2": "8.50",
          "chgp": "-25.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "703.38",
          "val2": "561.55",
          "chgp": "25.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "28.45%",
          "val2": "23.53%",
          "chgp": "4.92%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4,281.59",
          "val2": "3,368.11",
          "chgp": "27.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,171.04",
          "val2": "871.06",
          "chgp": "34.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "9.45",
          "val2": "14.30",
          "chgp": "-33.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "856.50",
          "val2": "636.59",
          "chgp": "34.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "27.35%",
          "val2": "25.86%",
          "chgp": "1.49%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Mar'26 - YoYstock-summary

Mar'26
Mar'25
Change(%)
Net Sales
937.67
989.13
-5.20%
Operating Profit (PBDIT) excl Other Income
218.31
209.65
4.13%
Interest
3.11
5.77
-46.10%
Exceptional Items
0.00
0.00
Standalone Net Profit
153.13
156.10
-1.90%
Operating Profit Margin (Excl OI)
23.28%
21.20%
2.08%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in quarter ended Mar 2026 is -5.20% vs -0.90% in Mar 2025

Direction Arrows
Standalone Net Profit

YoY Growth in quarter ended Mar 2026 is -1.90% vs 1.12% in Mar 2025

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
2,084.01
2,060.16
1.16%
Operating Profit (PBDIT) excl Other Income
550.93
408.82
34.76%
Interest
3.67
1.88
95.21%
Exceptional Items
0.00
0.00
Standalone Net Profit
401.92
292.96
37.19%
Operating Profit Margin (Excl OI)
26.44%
19.84%
6.60%
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

Nine Monthly Results Snapshot (Standalone) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
3,343.92
3,306.41
1.13%
Operating Profit (PBDIT) excl Other Income
952.73
779.75
22.18%
Interest
6.34
8.50
-25.41%
Exceptional Items
0.00
0.00
Standalone Net Profit
703.38
561.55
25.26%
Operating Profit Margin (Excl OI)
28.45%
23.53%
4.92%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is 1.13% vs 1.29% in Dec 2024

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2025 is 25.26% vs -5.46% in Dec 2024

Annual Results Snapshot (Standalone) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
4,281.59
3,368.11
27.12%
Operating Profit (PBDIT) excl Other Income
1,171.04
871.06
34.44%
Interest
9.45
14.30
-33.92%
Exceptional Items
0.00
0.00
Standalone Net Profit
856.50
636.59
34.54%
Operating Profit Margin (Excl OI)
27.35%
25.86%
1.49%
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

stock-summaryCompany CV
About Procter & Gamble Hygiene & Health Care Ltd. stock-summary
stock-summary
Procter & Gamble Hygiene & Health Care Ltd.
Mid Cap
FMCG
Procter & Gamble Hygiene and Health Care Limited (P&GHHCL) is engaged in manufacturing and selling of branded packaged fast moving consumer goods in the femcare and healthcare businesses. The Company's products are sold through retail operations including mass merchandisers, grocery stores, membership club stores, drug stores, department stores and high frequency stores.
Company Coordinates stock-summary
Company Details
P & G Plaza Chakala, Cardinal Gracias Rd Andheri(E) Mumbai Maharashtra : 400099
stock-summary
Tel: 91-22-28266000
stock-summary
investorpghh.i@pg.com
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai